Home > Products > CD33 & DENV
> Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-Fc-VHH)
Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-Fc-VHH) (CAT#: HCAB-035)
Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-Fc-VHH, Tetravalent HCAb) is a fusion protein of two diabodies connected together by an Fc region. In a diabody, the two VHHs with short linkers are from anti-CD33 and anti-DENV antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to the Fc fragment, which results in 2+2 antigen-binding valency and exerts Fc-mediated functions or just extends the half-life. This BsAb is designed for the research of antibody-dependent enhancement (ADE) and dengue virus infection.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-Fc-VHH) (HCAB-035). Click the button below to contact us or submit your feedback about this product.